A patient with worsening hepatic encephalopathy and ascites is being treated with lactulose and diuretics. Which nursing intervention is most important to prioritize in this patient's care?

C) Assess mental status every shift.

A) Measure abdominal girth daily.

B) Monitor serum ammonia levels weekly.

C) Assess mental status every shift.

D) Administer albumin infusion before diuretics.

A patient with a history of liver cirrhosis presents with worsening ascites and hepatic encephalopathy. The healthcare team has adjusted the treatment plan to include an increased dose of lactulose, diuretic therapy, albumin infusion, and a sodium-restricted diet. Which nursing intervention is most critical to assess the effectiveness of these interventions?

B) Assess neurological status regularly.

A) Monitor serum sodium levels.

B) Assess neurological status regularly.

C) Measure abdominal girth daily.

A patient with end-stage liver failure is showing signs of potential hepatorenal syndrome, with increasing serum creatinine and decreased urine output, despite ongoing management. Which nursing intervention is most appropriate to prioritize in this situation?

C) Monitor blood pressure closely and prepare for vasoconstrictor therapy.

A) Increase fluid intake to improve renal perfusion.

B) Administer lactulose to further reduce ammonia levels.

C) Monitor blood pressure closely and prepare for vasoconstrictor therapy.

D) Encourage mobility to enhance circulation and reduce abdominal distension.

A patient with end-stage liver failure is experiencing progression towards hepatorenal syndrome, as indicated by increasing serum creatinine and decreased urine output. The healthcare team is considering the use of vasoconstrictor therapy to support renal perfusion. Which of the following nursing interventions is most appropriate to prioritize when monitoring this patient's response to the therapy?

A) Monitor blood pressure closely and adjust fluid therapy as needed.

B) Increase lactulose dosage to enhance ammonia elimination.

C) Encourage high-protein diet to support liver function.

D) Perform daily abdominal girth measurements to assess for ascites.

A patient with end-stage liver failure is showing signs of early-stage hepatorenal syndrome with elevated liver enzymes, high bilirubin, and a low serum albumin level. Which nursing intervention is most appropriate to address the patient's current condition and prevent further complications?

C) Prepare for albumin infusion to support circulatory function.

A) Administer lactulose to decrease ammonia levels.

B) Initiate a high-protein diet to promote liver regeneration.

C) Prepare for albumin infusion to support circulatory function.

D) Encourage increased oral fluid intake to improve renal perfusion.

A patient with end-stage liver failure is showing signs of worsening liver function and early-stage hepatorenal syndrome. The healthcare team has decided to initiate low-dose vasoconstrictor therapy with terlipressin. Which of the following nursing interventions is most appropriate to prioritize in this situation?

A) Monitor the patient's blood pressure closely to assess for signs of hypotension.

B) Educate the patient about dietary restrictions to manage fluid retention.

C) Prepare the patient for immediate dialysis to address renal impairment.

D) Schedule routine liver function tests to evaluate the response to therapy.

A nurse is caring for a patient with end-stage liver failure who has developed new-onset ascites and signs of hepatic encephalopathy. Which of the following interventions should the nurse prioritize to address the patient's altered mental status?

B) Initiate lactulose therapy to reduce ammonia levels

A) Administer terlipressin to improve renal function

B) Initiate lactulose therapy to reduce ammonia levels

C) Perform large-volume paracentesis to alleviate ascites

A patient with end-stage liver disease presents with new-onset ascites, mild hypotension, and signs of hepatic encephalopathy. Which nursing intervention should take priority to address the patient's current condition?

A) Administer lactulose to reduce ammonia levels and manage hepatic encephalopathy.

B) Prepare the patient for large-volume paracentesis to relieve abdominal distension and improve respiratory function.

D) Initiate fluid restriction to manage ascites and prevent further fluid accumulation.

A patient with liver cirrhosis has undergone a large-volume paracentesis and is now receiving albumin infusion due to low serum albumin levels. Her ammonia levels remain elevated despite lactulose therapy, and she is experiencing intermittent confusion and drowsiness. Which nursing intervention is most appropriate to prioritize in this situation?

B) Monitor neurological status closely and prepare for potential administration of rifaximin.

A) Increase the frequency of lactulose administration to every hour.

B) Monitor neurological status closely and prepare for potential administration of rifaximin.

C) Restrict fluid intake to prevent further ascites accumulation.

D) Educate the patient and family about the importance of low-protein diet to reduce ammonia levels.

A patient has undergone a large-volume paracentesis, resulting in the removal of 4 liters of ascitic fluid. Post-procedure, the patient reports reduced abdominal discomfort and improved respiratory function. Her serum albumin is critically low at 2.0 g/dL, and she is experiencing fluctuating mental status despite lactulose therapy. Which nursing intervention is most appropriate to address her current condition?

C) Monitor for signs of hypovolemia and administer albumin infusion as ordered.

A) Administer additional diuretics to prevent fluid reaccumulation.

B) Initiate a high-protein diet to increase serum albumin levels.

C) Monitor for signs of hypovolemia and administer albumin infusion as ordered.

D) Encourage increased oral fluid intake to compensate for fluid loss.

end stage liver failure - Nursing Case Study

Pathophysiology

• Primary mechanism: Chronic liver damage leads to fibrosis and cirrhosis, impairing liver functions such as detoxification, protein synthesis, and metabolism. This results in the accumulation of toxins, including ammonia, causing hepatic encephalopathy.

• Secondary mechanism: Portal hypertension occurs due to increased resistance to blood flow in the fibrotic liver, leading to the development of varices and ascites. This exacerbates the risk of bleeding and infection.

• Key complication: Hepatorenal syndrome can arise, where reduced blood flow to the kidneys leads to renal failure, further complicating fluid balance and waste elimination.

Patient Profile

Demographics:

62-year-old female, retired school teacher

History:

• Key past medical history: Chronic Hepatitis C, Type 2 Diabetes, Hypertension

• Current medications: Lactulose, Spironolactone, Metformin, Lisinopril

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing abdominal distension and confusion

• Key symptoms: Jaundice, fatigue, peripheral edema, pruritus, episodic confusion

• Vital signs: Blood pressure 102/68 mmHg, Heart rate 88 bpm, Respiratory rate 20 breaths/min, Temperature 37.5°C, Oxygen saturation 94% on room air

Section 1

As the healthcare team proceeds with the initial assessment, they note that the patient's abdominal distension has worsened. Upon examination, there is significant ascites present, and a fluid wave test confirms a large volume of fluid accumulation in the abdominal cavity. The patient's skin and sclera are markedly icteric, indicating high bilirubin levels. She is also experiencing increased fatigue and confusion, raising concerns about worsening hepatic encephalopathy. The nursing assessment reveals mild asterixis, and her Glasgow Coma Scale score has decreased to 13, indicating a moderate degree of encephalopathy.

Laboratory results further elucidate the patient's deteriorating condition. Her serum ammonia level has risen to 145 µmol/L, which correlates with her confusion and asterixis. Liver function tests show a significant increase in bilirubin at 5.6 mg/dL, an elevated INR of 2.1, and a marked decrease in albumin to 2.4 g/dL, reflecting compromised liver synthetic function. Renal function is also affected, with serum creatinine rising to 1.8 mg/dL from a baseline of 1.2 mg/dL, suggesting the potential onset of hepatorenal syndrome. These findings necessitate a reevaluation of her current management plan, focusing on optimizing her fluid balance and reducing ammonia levels.

The team decides to adjust her treatment regimen. Lactulose dosage is increased to address elevated ammonia levels and mitigate hepatic encephalopathy. Diuretic therapy is carefully monitored, considering the risk of exacerbating renal impairment. An albumin infusion is ordered to help manage her hypoalbuminemia and ascites. The patient is also placed on a sodium-restricted diet to control fluid retention. As these interventions are implemented, the healthcare team closely monitors her response, particularly her cognitive function and renal parameters, to guide further treatment decisions.

Section 2

As the healthcare team continues to monitor the patient's condition, they notice a change in her status that prompts further evaluation. Over the next 48 hours, her mental status shows slight improvement, with her Glasgow Coma Scale score rising to 14 following the increased lactulose therapy. The frequency of bowel movements has increased, suggesting effective clearance of ammonia, yet the patient remains lethargic, and mild confusion persists. Her asterixis has somewhat diminished, indicating a positive, albeit modest, response to the treatment.

However, the patient's renal function raises concern. Her serum creatinine level has increased further to 2.2 mg/dL, and urine output has decreased significantly, suggesting progression towards hepatorenal syndrome, a severe complication associated with end-stage liver failure. Blood pressure readings are stable but on the lower side, with a systolic pressure averaging around 95 mmHg, which necessitates careful fluid management. Her weight has decreased slightly, indicating some reduction in fluid overload, but the abdominal distension remains pronounced, and repeat paracentesis is considered to alleviate discomfort and prevent respiratory compromise.

These developments highlight the complexity of her condition, requiring the team to balance therapeutic interventions delicately. The decision is made to adjust diuretic therapy further, cautiously optimizing doses to address fluid retention while minimizing renal stress. Meanwhile, the team considers advanced interventions, such as vasoconstrictor therapy, to support renal perfusion and potentially slow the progression of renal dysfunction. The patient is scheduled for a nephrology consultation to explore additional strategies for managing her renal status in the context of her liver failure. This evolving clinical picture underscores the need for ongoing assessment and dynamic adjustment of her care plan to manage the intertwined complications effectively.

Section 3

New Diagnostic Results:

As the healthcare team continues to navigate the complexity of the patient's condition, new diagnostic results provide further insight into her evolving status. A repeat liver function panel shows a slight worsening of her hepatic enzymes, with AST and ALT levels now elevated to 130 IU/L and 115 IU/L, respectively. Her bilirubin remains high at 5.4 mg/dL, indicating persistent cholestasis and liver dysfunction despite efforts to manage her condition. The patient's INR has also increased to 2.0, suggesting a further decline in her liver's synthetic function and increasing her risk of bleeding complications.

The nephrology consultation reveals that the patient's renal impairment is consistent with early-stage hepatorenal syndrome. Urinary sodium excretion is low at 10 mmol/L, supporting the diagnosis and the need for targeted intervention. The decision is made to initiate low-dose vasoconstrictor therapy with terlipressin to improve renal perfusion and potentially halt the progression of renal failure. Meanwhile, serum albumin levels are checked and found to be low at 2.3 g/dL, prompting consideration of albumin infusion to support circulatory function and enhance the efficacy of the vasoconstrictor therapy.

These diagnostic findings necessitate a re-evaluation of her care plan, emphasizing the importance of close monitoring and timely response to changes in her condition. The team discusses the potential for a multidisciplinary approach, involving hepatology and nephrology experts, to optimize her management and explore options such as liver transplantation evaluation in light of her deteriorating liver function and the onset of hepatorenal syndrome. The care team remains vigilant, aware that the patient's journey will require dynamic and coordinated efforts to address the intertwined complications of her end-stage liver failure.

Section 4

Change in Patient Status:

Over the next 48 hours, the patient's clinical status reflects both positive and concerning changes. There is a modest improvement in renal function, as evidenced by an increase in urinary output and a slight rise in urinary sodium excretion to 15 mmol/L, suggesting a positive response to the initiated terlipressin therapy. However, her overall condition remains precarious as her liver function continues to deteriorate. She develops new-onset ascites, with a noticeable abdominal distension and discomfort. Ultrasound confirms the presence of moderate ascitic fluid accumulation, further complicating her clinical picture.

Vital signs reveal a mild hypotension with blood pressure readings averaging 95/60 mmHg, and a heart rate that has risen to 110 beats per minute, indicative of compensatory tachycardia. Her respiratory rate is slightly elevated at 22 breaths per minute, and she reports increased fatigue and dyspnea on exertion. Her oxygen saturation remains stable at 94% on room air. The patient's mental status is also subtly altered; she is more lethargic and exhibits occasional confusion, raising concerns about hepatic encephalopathy. Her ammonia levels are checked and found to be elevated at 85 µmol/L, necessitating the initiation of lactulose therapy to prevent further encephalopathy progression.

These developments prompt the healthcare team to intensify monitoring and adjust her management plan. The appearance of ascites and signs of encephalopathy highlight the need for continued multidisciplinary collaboration. The team discusses the potential benefits of a large-volume paracentesis to alleviate her symptoms and improve respiratory function. Additionally, the patient's candidacy for liver transplantation becomes more urgent, as her MELD score has increased, reflecting her deteriorating liver function. The team also considers the use of non-selective beta-blockers to manage portal hypertension and minimize bleeding risk, while being mindful of her hypotension. This multifaceted approach underscores the complexity of her care and the critical need for timely interventions to address the evolving challenges of end-stage liver failure.

Section 5

In the following 24 hours, the patient undergoes a large-volume paracentesis, which successfully removes 4 liters of ascitic fluid. Post-procedure, she reports a significant reduction in abdominal discomfort and dyspnea, suggesting an improvement in her respiratory function. Her vital signs post-paracentesis show a slight improvement, with blood pressure stabilizing at 100/65 mmHg and heart rate decreasing to 98 beats per minute. While these changes are positive, her overall status remains fragile. Laboratory results reveal that her serum albumin is critically low at 2.0 g/dL, prompting the initiation of albumin infusion to address potential hypovolemia and maintain circulatory stability.

Despite these interventions, the patient's mental status continues to fluctuate. Although lactulose therapy has been initiated, her ammonia levels remain persistently elevated, now at 92 µmol/L. She experiences intermittent confusion and drowsiness, signaling a need for further adjustment of her hepatic encephalopathy management plan. The healthcare team deliberates on potentially adding rifaximin to her regimen to enhance the efficacy of her current treatment and mitigate the risk of further neurological decline.

In parallel, the multidisciplinary team is closely reviewing her eligibility for liver transplantation. Her MELD score now stands at 30, underscoring the urgency for transplantation listing. The team initiates discussions with the patient and her family about the next steps, including potential placement on the transplant list and the challenges and expectations surrounding the procedure. These developments highlight the critical balance between managing acute symptoms and planning for long-term solutions in her care trajectory, urging the team to remain vigilant and adaptive in their management strategies.